NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Zydus vaccine for 12-18-year-olds from September, says expert panel chief
    Zydus vaccine for 12-18-year-olds from September, says expert panel chief
    India

    Zydus vaccine for 12-18-year-olds from September, says expert panel chief

    Written by Sagar
    July 09, 2021 | 01:07 pm 3 min read
    Zydus vaccine for 12-18-year-olds from September, says expert panel chief
    COVID-19 vaccination for children in India will start by September, said expert panel chief Dr. NK Arora.

    Coronavirus vaccination for children with the Zydus Cadila vaccine will start by September, said Dr. NK Arora, the chief of National Expert Group on Vaccine Administration. Zydus had applied for the Emergency Use Authorization (EUA) of its vaccine a few days ago and approval is expected in the next couple of weeks, he added. There is no approved vaccine for children in India yet.

    'We should be able to give it by September-end'

    "By the end of September we should be able to give it," Dr. Arora told NDTV. "The issue of school opening and other things are very important and those are being discussed actively (sic)."

    Jab found 66.6% effective against symptomatic cases

    Zydus's vaccine, called ZyCoV-D, was found safe and effective in a late-stage trial involving more than 28,000 volunteers across India. That trial also included 1,000 subjects in the 12-18 year age group, the company said. The jab is 66.6 percent effective against symptomatic cases of COVID-19 and 100 percent effective against moderate disease, according to the company.

    What makes this vaccine unique?

    When approved, ZyCoV-D will become the world's first DNA vaccine against the coronavirus. Unlike most COVID-19 vaccines, this jab comes with a three-dose regimen and can be applied through a "needle-free" system, the company said.

    2 more vaccines for children are in the pipeline

    Apart from ZyCoV-D, India could have at least two more coronavirus vaccines for children in the near future. Bharat Biotech, which produces the indigenous jab COVAXIN, is currently testing the vaccine on children. Further, Pfizer's COVID-19 vaccine is already approved for use in children in foreign countries, implying when India approves it, that could be another option for children in the country.

    Will third COVID-19 wave affect children harder?

    There has been speculation that a third wave of COVID-19 will affect children harder. However, experts have said there is no evidence available yet to prove that theory. A seroprevalence study done by the World Health Organization and the All India Institute of Medical Sciences showed the level of antibodies was quite similar among both adults and children.

    How is India's vaccination drive going?

    India began its coronavirus vaccination program in January and has since administered over 36 crore vaccine doses. Even though more than 21% of Indians have received at least one vaccine shot, just about 5% have been fully inoculated as yet. India has so far given approval to four vaccines - COVAXIN, Oxford-AstraZeneca's Covishield, Russia's Sputnik V, and Moderna.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Zydus Cadila
    Coronavirus
    COVID-19
    COVID-19 Vaccine
    COVAXIN

    Zydus Cadila

    Zydus applies for approval of its 3-dose, needle-free COVID-19 vaccine Drugs Controller General of India
    Zydus to seek approval for its COVID-19 vaccine next week India
    Zydus seeks human trial approval for its COVID-19 antibody cocktail Coronavirus
    Zydus Cadila's antiviral drug approved for treating moderate COVID-19 cases India

    Coronavirus

    No room for carelessness, complacency: PM Modi on COVID-19 situation Narendra Modi
    DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG Defence Research and Development Organisation (DRDO)
    US coronavirus cases rising sharply as Delta variant spreads Joe Biden
    Global COVID-19 deaths hit four million amid rush to vaccinate COVID-19

    COVID-19

    New drug target to treat coronavirus, fight future pandemic found Research
    Indraprastha Apollo records six cytomegalovirus infection cases in a month Delhi
    Tokyo 2020 Olympics to be held under state of emergency Yoshihide Suga
    Third COVID-19 wave: Delhi government panel devises color-coded response system Delhi

    COVID-19 Vaccine

    Morepen Laboratories starts production of test batch of Sputnik V Coronavirus
    Recipe for even more powerful vaccines against COVID-19 found Research
    IISc-Bengaluru preparing booster shot that works for any COVID-19 vaccine India
    Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass' European Union Intellectual Property Office (EUIPO)

    COVAXIN

    COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech COVID-19
    Bharat Biotech denies wrongdoing in $324mn COVAXIN deal with Brazil Vaccine
    COVAXIN effectively neutralizes the Delta variant, top US body says Coronavirus
    COVAXIN for children aged 2-18 by September, says AIIMS chief India
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023